Intrauterine exposure to diethylstilbestrol: Long-term effects in humans

APMIS, Supplement

Volumn 109, Issue 103, 2001, Pages

  Swan, S H ^a   Meyer, H ^a   Swan, S ^a   McLachlan, J ^a   Soto, A ^a   Callard, G ^a   Brandi, M ^a   Newbold, R ^a  

^a University of Missouri   (United States)

Author keywords

Cancer; Diethylstilbestrol; Epidemiology; Reproduction; Transplacental carcinogenesis

Indexed keywords

DIETHYLSTILBESTROL;

CLEAR CELL CARCINOMA; CONFERENCE PAPER; FEMALE; GENITAL MALFORMATION; GESTATIONAL AGE; HUMAN; MALE; MALE GENITAL SYSTEM DISEASE; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; TERATOGENESIS; TRANSPLACENTAL CARCINOGENESIS; UTERINE CERVIX DISEASE; UTERUS DISEASE; VAGINA CARCINOMA; VAGINA DISEASE;

EID: 0034912895     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (75)

1. Sex hormones and cancer-producing compounds
2. Exposure to a xenoestrogen before birth: The diethylstilbestrol experience
3. Developmental exposure to estrogens induces persistent changes in skeletal tissue
4. Alterations in immune responsiveness in women exposed to diethylstilbestrol in utero
5. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol
6. Immunologic studies of women exposed in utero to diethylstilbestrol
7. Prevention of abortion
8. Pregnancies observed in the likely-to-abort patient with or without hormone therapy before of after conception
9. Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project
10. Diethylstilbestrol in pregnancy. Frequency of exposure and usage patterns
11. Does the administration of diethylstilbestrol during pregnancy have therapeutic value?
12. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix
13. Males exposed in utero to diethylstilbestrol
14. Diethylstilbestrol revisited: A review of the long-term health effects
15. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas)
16. Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women
17. Vaginal cancer after maternal treatment with synthetic estrogens
18. Certain estrogens for oral or parenteral uses
19. Drug's use linked to adenocarcinoma in the offspring
20. Vaginal and cervical abnormalities after exposure to stilbestrol in utero
21. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update
22. Vaginal clear cell adenocarcinoma in the United States
23. Diethylstilboestrol and diethylstilboestrol dipropionate
24. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens
25. Follow-up study of male and female offspring of DES-treated mothers a preliminary report
26. Benign cervical and vaginal changes associated with exposure to stilbestrol in utero
27. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero
28. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol
29. Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project
30. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol
31. Upper genital tract changes and infertility in diethylstilbestrol-exposed women
32. Diethylstilbestrol-induced upper genital tract abnormalities
33. Structure and function of the fallopian tubes following exposure to diethylstilbestrol (DES) during gestation
34. Cellular and molecular effects of developmental exposure to diethylstilbestrol: Implications for other environmental estrogens
35. Vaginal adenosis in stillborns and neonates exposed to diethylstilbestrol and steroidal estrogens and progestins
36. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project
37. Pathology of infertility and adverse pregnancy outcome after in utero exposure to diethylstilbestrol
38. Pregnancy outcomes in DES daughters
39. Synthetic estrogens suppress granulosa cell progesterone production in vitro
40. Effect of diethylstilbestrol on reproductive function
41. Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol
42. Reproductive outcome of women exposed to diethylstilbestrol in utero
43. Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters
44. Pregnancy outcome in 98 women exposed to diethylstilbestrol in utero, their mothers, and unexposed siblings
45. Infertility among daughters either exposed or not exposed to diethylstilbestrol
46. Adverse out-comes of pregnancy in women exposed to diethylstilbestrol in utero
47. Antepartum and intrapartum events in women exposed in utero to diethylstilbestrol
48. A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: Long-term follow-up of mothers and their offspring
49. Risk factors for cancer of the testis in young men
50. The epidemiology of testicular cancer in young adults
51. Hormonal risk factors in testicular cancer
52. Estrogen exposure during gestation and risk of testicular cancer
53. Prenatal and perinatal risk factors for testicular cancer
54. A case-control study of testicular cancer using Connecticut tumour registry data
55. Maternal and gestational factors affecting the risk of cryptorchidism and inguinal hernia
56. Follow-up study of male and female offspring of DES-exposed mothers
57. Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero
58. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities
59. Fertility in men exposed prenatally to diethylstilbestrol
60. Urogenital tract abnormalities in sons of women treated with diethylstilbestrol
61. Male genitourinary abnormalities and maternal diethystilbestrol
62. Transplacental exposure to diethylstilbestrol in men
63. Genital tract examinations and zona-free hamster egg penetration tests from men exposed in utero to diethylstilbestrol
64. Effects of prenatal exposure to diethylstilbestrol(DES) on hemispheric laterality and spatial ability in himan males
65. A statewide approach to diethylstilbestrol - The New York program
66. Use of diethylstilbestrol to prevent fetal loss from complications of late pregnancy
67. Induced genital anomalies
68. Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic
69. Report of the recommendations of the 1985 DES Task Force of the U.S. Department of Health and Human Services
70. Physical and psychological effects of DES on exposed offspring
71. Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: II. Effects of DES on development
72. DES banned in cattle, sheep